RECRUITING

The Role of hCG in Thawed Embryo Transfer

Talk to us

Conditions

Infertility (IVF Patients)Thawed embryo transfer

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.

Official Title

The Role of hCG in Thawed Embryo Transfer

Quick Facts

Study Start:2025-06-02
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07004192

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Female adult expecting to receive transfer of a thawed embryo.
  2. 2. At least one available frozen blastocyst of transferrable quality.
  3. 3. Non-menopausal female with at least one antral follicle.
  4. 4. Use of pre-implantation genetic testing (PGT), embryos derived from donor oocytes and/or donor sperm, a gestational carrier, and history of prior transfer(s) regardless of outcome are allowed.
  5. 5. Subsequent embryo transfers after failed transfers under this study are allowed, but not after a transfer that has resulted in ongoing pregnancy at ten weeks gestation under this study.
  1. 1. Minors (age\<18 years).
  2. 2. Use of embryo(s) frozen at another center.
  3. 3. Patient insistent on transfer of two embryos.
  4. 4. Patient or partner unable to provide informed consent in English.
  5. 5. Patient already enrolled in any other research study for her embryo transfer.
  6. 6. History of anti-phospholipid syndrome or any other indication for use of Lovenox in pregnancy.
  7. 7. Patient for whom the physician assesses this protocol is inappropriate or unsafe.

Contacts and Locations

Study Contact

Shironda Research Assistant
CONTACT
702-254-1777
shironda@fertilitycenterlv.com

Study Locations (Sites)

Fertility Center of Las Vegas
Las Vegas, Nevada, 89113
United States

Collaborators and Investigators

Sponsor: Fertility Center of Las Vegas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-02
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2025-06-02
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • Thawed embryo transfer

Additional Relevant MeSH Terms

  • Infertility (IVF Patients)